News | National Commission on Correctional Health Care
As we work with more facilities seeking to treat patients with opioid use disorder, a specific challenge has emerged with injectable extended-release naltrexone (XR-NTX).
As our approach to COVID-19 takes a new turn with the introduction of vaccines, it’s time to prepare for educating staff and incarcerated people
by James W. Grigg, MD, Ross MacDonald, MD, and Rachael Bedard, MD. A significant amount of national attention has focused on the risks of coronavirus
Centurion Health has made a generous gift to the NCCHC Foundation in support of conference scholarships.
2021 welcome jpg e1609277319526
by Joseph V. Penn, MD, CCHP-MH As we bid farewell to 2020 and welcome 2021, I hope that you are feeling encouraged by the
coronavirus behind bars e1609262088119
Q: I am concerned about maintaining our facility’s accreditation status because, in response to COVID, we have made some changes in the way we
Substances referred to in the community as “Tranq” and “Frankenstein” have increased the potency and dangers related to opioid abuse.
CCHP logo
The CCHP program has launched a new digital “badge” option for all CCHPs.
Pauline M for blog
The most amazing part of working in an electronic environment is accessibility.
Fall 2023 CorrectCare
Download the new issue of CorrectCare.
emily hoff 680x510
This annual award recognizes outstanding research and published work of women and underrepresented minority scientists, physicians, and engineers.
Q and A 680x510 1
What are acceptable ways for destruction of a controlled medication dose that is dropped?